Laetitia Canini

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Ejection Fraction

Affordable Care Act

Loop Mediated Isothermal Amplification

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Veterinary research

Journal of virology

This page only lists publications with an associated author ORCID identifier.

Publications

Hélène Duault, Lorraine Michelet, Maria-Laura Boschiroli, Benoit Durand, Laetitia Canini
A Bayesian evolutionary model towards understanding wildlife contribution to F4-family Mycobacterium bovis transmission in the South-West of France. Veterinary research 53 (1) (2022)
Helen E Everett, Pauline M van Diemen, Mario Aramouni, Andrew Ramsay, Vivien J Coward, Vincent Pavot, Laetitia Canini, Barbara Holzer, Sophie Morgan, null null, Mark E J Woolhouse, Elma Tchilian, Sharon M Brookes, Ian H Brown, Bryan Charleston, Sarah C Gilbert
Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza A Virus Infection to Unvaccinated Pigs. Journal of virology 95 (4) (2021)
Laetitia Canini, Barbara Holzer, Sophie Morgan, Johanneke D Hemmink, Becky Clark, null null, Mark E J Woolhouse, Elma Tchilian, Bryan Charleston
Timelines of infection and transmission dynamics of H1N1pdm09 in swine. PLoS pathogens 16 (7) (2020)
Martina Gambato, Laetitia Canini, Sabela Lens, Frederik Graw, Elena Perpiñan, Maria-Carlota Londoño, Susan L Uprichard, Zoe Mariño, Enric Reverter, Concepcio Bartres, Patricia González, Anna Pla, Josep Costa, Patrizia Burra, Scott J Cotler, Xavier Forns, Harel Dahari
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis. Liver international : official journal of the International Association for the Study of the Liver 39 (5) (2018)
Laetitia Canini, Michio Imamura, Yoshiiku Kawakami, Susan L Uprichard, Scott J Cotler, Harel Dahari, Kazuaki Chayama
HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients. PloS one 12 (12) (2017)